Workforce Upskilling in Pharma R&D

Pharma R&D Today

Along the way, scientists from these big pharma organizations rallied around their in-house data science experts and Elsevier consultants enabled these multidisciplinary teams to challenge each other and learn from one another. Pharma R&D API data science pandemic Reaxys upskilling

Innovation in insulin delivery: Two companies look to transform diabetes treatment

BioPharma Reporter

Multiple pharma R&D teams are seeking to transform how diabetes treatment is managed. Markets & Regulations

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Despite COVID-19, pharma R&D funding at all-time high: IQVIA

Outsourcing Pharma

According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.

Why VCs fell in love with pharma R&D in 2021

Pharma Phorum

For many years, those inside the pharma industry have been telling the same old story about innovation: pharma is big, slow, and risk averse. That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity.

Annual pharma R&D spending in UK climbed 6.9% in 2019

Pharma Times

R&D spending in the sector last year represents an eight-year high

Pharma R&D investment report shows positive signs: Deloitte

Outsourcing Pharma

According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

Transforming pharma R&D with a scientist-centric approach to AI & automation

Pharma Phorum

Markus Gershater looks at how automation and artificial intelligence (AI) can transform pharma R&D. The post Transforming pharma R&D with a scientist-centric approach to AI & automation appeared first on.

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D

BioTech 365

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D ? Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients ? … Continue reading → Business Wire

Reaxys User Day 2022: Researcher secrets in the spotlight

Elsevier

Chemistry Pharma R&D AI compounds Reaxys Reaxys User Day synthetic chemistryIn April, Elsevier hosted the first Reaxys User Day to learn from expert users and share best practices.

#news #biotech Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months

BioTech 365

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months.Chutes & Ladders—Arena Pharma R&D chief Cabell leaves post after 6 months kblankenship Thu, 12/03/2020 – … Continue reading → #news

Pharma can now track the most relevant patent info – fast and at scale

Elsevier

AI & Data Chemistry Pharma R&D biological targets data science deep learning indexing models patent expansion patents Reaxys

Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science

BioTech 365

Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science Pharma R&D Activity Surges Even Without COVID-19, Says Report from the IQVIA Institute for Human Data Science Funding for early- and late-stage R&D … Continue reading → Business Wire

Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for Human Data Science Report

BioTech 365

Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for Human Data Science Report Pharma R&D Pipeline and New Product Launches Reach Record Levels in 2021 According to New IQVIA Institute for … Continue reading → Business Wire

BPT Analytics Ltd. launches cloud-based analytics dashboard “A Landscape of Artificial Intelligence (AI) In Pharma R&D”

BioTech 365

First analytics dashboard tracking and visualizing data about AI-driven biotech startups and AI vendors in pharma space, supported by data aggregation engine LONDON & KYIV, Ukraine–(BUSINESS WIRE)–#artificialintelligence–BPT Analytics Ltd.

Taking on the Net Zero challenge at the government level

Elsevier

As discussed in a previous post, Pharma’s path to Net Zero , pharmaceutical operations are responsible for a significant amount of greenhouse gas emissions, driving many industry players to make Net Zero pledges.

Pharma’s path to Net Zero

Elsevier

Pharma is seldom top of mind when thinking about the most polluting industries, but pharmaceutical industry operations are in fact responsible for a significant portion of the world’s greenhouse gas emissions – even rivaling industries that are far more associated with contributing to the problem.

Elsevier research partner Karin Verspoor nominated For Women in AI award

Elsevier

Empowering Pharma to work better and faster. Her ChEMU collaboration is aimed at helping chemists and pharma companies do their work as efficiently and effectively as possible. Network.

How publishing can help address diversity in STEM

Elsevier

The Pistoia Alliance, an organization of over 100 companies (including Elsevier) that are committed to advancing R&D in the life sciences, has just launched a Women in STEM leadership pilot program that will involve several major players in pharma like Bayer, GSK, Merck, Roche, Pfizer and more.

The power of similarities to accelerate antiviral development for COVID-19

Elsevier

COVID-19 Pharma R&D antiviral data Hepatitis C Pfizer protease inhibitor SARS-CoV-2

Elsevier and LG: Turning data into action

Pharma R&D Today

There are life-changing insights waiting to be found in chemistry data. The critical information waiting to be unlocked can lead to incredible technology advances and medical breakthroughs. But there is so much data out there, and it is multiplying rapidly.

Data Science & AI amplifies your innovative drug R&D capabilities

Elsevier

However, if you are not Big Pharma, it’s the how that slows down most LSH companies and organizations. AI & Data Pharma R&D AI data science digital transformation Embase Entellect life science data Reaxys

Reaxys User Day 2022: Sharing insights and tips for streamlining the chemist workflow

Pharma R&D Today

But if you are working in big pharma with scaling in mind you may opt for greener options,” he explains.

Emerging trends for pancreatitis in the scientific literature: a new report

Elsevier

Pharma R&D data science pancreatitis Professional Services scientific literature text miningElsevier has just released the Emerging trends for pancreatitis in the scientific literature report, which identifies proteins and genes linked to pancreatitis.

Busy healthcare professionals can rely on phactMI

Pharma R&D Today

A consortium of 30+ pharma and biotech companies, phactMI is dedicated to delivering crucial and reliable drug information to the healthcare professionals when and where they need it.

Accelerating synthetic chemistry with a predictive retrosynthesis solution

Elsevier

AI & Data Chemistry Pharma R&D algorithms data Pending.AI In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting.

How pharma can make drug information accessible

Pharma R&D Today

One great initiative has been the establishment of the Pharma Collaboration for Transparent Medical Information (also known as phactMI ), a consortium of 30 pharmas that includes major companies like AstraZeneca, Bayer, Gilead, GSK, Merck, Pfizer and many more. “We

phactMI: Delivering accurate drug information to point of care, part IV

Pharma R&D Today

The Pharma Collaboration for Transparent Medical Information ( phactMI ) is a non-profit organization that seeks to improve the lives of patients by supporting the safe and effective use of medicines.

phactMI: Delivering accurate drug information to point of care

Pharma R&D Today

The Pharma Collaboration for Transparent Medical Information ( phactMI ) is one such undertaking. Part 1: How healthcare professionals can access the latest and most accurate information on medications.

phactMI: Delivering accurate drug information to point of care, part II

Pharma R&D Today

This is the goal of the Pharma Collaboration for Transparent Medical Information ( phactMI ), a 501(c)(6) that seeks to improve the lives of patients through the safe and effective use of medicines.

Umesh Nandal: Chemist and data scientist in one

Pharma R&D Today

The pipeline has proven a game-changer in how pharma companies can now speedily track the competitive landscape – and be alerted to any threats to the long-term patentability of a particular discovery project. Umesh Nandal is a Director of Data Science at Elsevier.

Modeling Coronavirus – Cytokine Storm

Pharma R&D Today

Figure 1. Classification of COVID-19 Disease States. Adapted from Sidiqi, H.K. and M.R. Mehra, COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. J Heart Lung Transplant, 2020. [1]. This piece was co-authored by Prof.

Beyond Reference Management: How Literature Management is a Win for the Life Science Organization

Pharma R&D Today

Pharma R&D access copyright compliance life sciences literature management Medical Affairs pharmacovigilance practices reference management scientific literature

Can predictive retrosynthesis become a valuable part of a chemist’s toolkit?

Pharma R&D Today

“Yes. I was amazed by the Reaxys Predictive Retrosynthesis technology,” says Moritz Classen of the Carreira Research Group at ETH Zurich. He and his colleagues spent months evaluating the tool as they applied it into their daily workflows. “It’s

What Excites You Most About the Life Sciences Industry in 2021?

Pharma R&D Today

Pharma R&D 2021 coronavirus COVID-19 drug repurposing genomics personalized medicine phactMI predictive tools QUOSA Reaxys therapeutics vaccines

Mutually empowering – semantic-based machine learning and subject matter expertise

Pharma R&D Today

In a day dedicated to emerging science and technologies at the Pistoia Alliance virtual conference Collaborative R&D in Action , SciBite CTO James Malone opened the program with a compelling exploration of use cases for semantic-based machine learning (ML).

AI-driven innovation in life sciences: Unlocking the page – 20+ years of digital innovation at Elsevier

Pharma R&D Today

Mark Sheehan is VP Data Science on Elsevier’s Life Science team. His 20 years at the company maps closely with Elsevier’s digital journey over that time. And today, pharmaceutical companies can follow a similar journey – albeit highly accelerated – using Elsevier’s latest AI-driven R&D boosters.

AI-driven innovation in life sciences: Data as data should be

Pharma R&D Today

Your AI applications are only as strong as your data. This is why Elsevier strives to make data not only align with FAIR usability principles but also be maximized for trustworthiness and relevance.

Big Data in Chemistry is featured in a new webinar series

Pharma R&D Today

We talk a lot about how innovation is driven by technological advances such as AI and machine learning – but equally important to innovation are partnerships and collaborations.

Technology and empathy help make remote working a success for Elsevier

Pharma R&D Today

Pharma R&D coronavirus COVID-19 Reaxys remote working Research work from home working remotelyWe at Elsevier were pleased to be one of five companies recognized for their ability to keep remote workers rooted in company culture in this recent Comparably article.

Finding drug information can be hard – healthcare providers need digital solutions

Pharma R&D Today

Currently, the Pharma Collaboration for Transparent Medical Information (phactMI) is providing one such source for evidence-based drug information via the powerful Entellect platform.

AI precision medicine accelerates the search for rare disease treatment

Pharma R&D Today

AI and precision medicine are both changing drug discovery and development as we know it. Precision medicine that is powered by AI stands to be transformative, especially for the treatment of rare diseases.

New Coronavirus Advisory Team Announced

Pharma R&D Today

Wasting no time to start enacting his forthcoming administration’s plan for tackling COVID-19, new president-elect of the United States, Joe Biden, has unveiled his coronavirus advisory team.

At the leading edge of an innovation hotspot: predictive reaction modeling

Pharma R&D Today

Indisputably, a surge in predictive machine learning models to support synthetic chemistry has galvanized a movement to make these tools effective R&D solutions. Reaxys has been part of this innovation journey from the beginning.